PARSACLISIB for Follicular lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where PARSACLISIB was used for Follicular lymphoma.
Most Reported Side Effects for PARSACLISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 23 | 31.1% | 1 | 8 |
| Disease progression | 15 | 20.3% | 1 | 1 |
| Pyrexia | 14 | 18.9% | 0 | 10 |
| Pneumonia | 11 | 14.9% | 0 | 9 |
| Bronchitis | 9 | 12.2% | 0 | 9 |
| Neutropenic sepsis | 9 | 12.2% | 0 | 9 |
| Neutrophil count decreased | 9 | 12.2% | 0 | 9 |
| Blood lactate dehydrogenase increased | 8 | 10.8% | 0 | 1 |
| Neutropenia | 8 | 10.8% | 1 | 2 |
| Hypokalaemia | 7 | 9.5% | 0 | 7 |
| Enterococcal bacteraemia | 6 | 8.1% | 0 | 0 |
| Intentional product use issue | 6 | 8.1% | 0 | 6 |
| Thrombocytopenia | 6 | 8.1% | 0 | 0 |
| Acute kidney injury | 5 | 6.8% | 1 | 4 |
| Alanine aminotransferase increased | 5 | 6.8% | 1 | 0 |
Other Indications for PARSACLISIB
Diffuse large b-cell lymphoma (24)
Mantle cell lymphoma (11)
B-cell lymphoma (6)
Product used for unknown indication (5)
Other Drugs Used for Follicular lymphoma
LENALIDOMIDE (3,611)
RITUXIMAB (3,294)
OBINUTUZUMAB (2,527)
BENDAMUSTINE (1,560)
CYCLOPHOSPHAMIDE (1,367)
VINCRISTINE (1,224)
DOXORUBICIN (1,115)
PREDNISONE (889)
TAZEMETOSTAT HYDROBROMIDE (439)
ETOPOSIDE (352)